USMLE Step 1 practice question: Cisplatin toxicity (ototoxicity, nephrotoxicity, hypomagnesemia): DNA cross-linking
USMLE Step 1Hematology/OncologyPharmacology
The drug most likely responsible for this patient's hearing loss exerts its antineoplastic effect by which of the following mechanisms?
- Inhibition of topoisomerase II
- Generation of free radicals that cause DNA strand breaks
- Inhibition of dihydrofolate reductase
- Formation of intrastrand DNA cross-links
- Inhibition of microtubule polymerization
Show answer and explanation
Correct answer: D. Formation of intrastrand DNA cross-links
This patient with a nonseminomatous germ cell tumor is most likely receiving BEP (bleomycin, etoposide, and cisplatin), the standard regimen for advanced testicular cancer. His new bilateral tinnitus and high-frequency sensorineural hearing loss, acute kidney injury, and renal magnesium and potassium wasting are characteristic toxicities of cisplatin.
Cisplatin is a platinum compound. Inside cells, where the chloride concentration is low, its chloride ligands are replaced by water (aquation), producing a reactive species that binds the N7 position of guanine. It forms predominantly 1,2-intrastrand cross-links between adjacent purines, as well as some interstrand cross-links, which distort the DNA helix, block replication and transcription, and trigger apoptosis. Its action is cell cycle–nonspecific.
Cisplatin toxicities: • Nephrotoxicity: accumulation in proximal tubule cells causes acute tubular injury with renal Mg2+ wasting (hypomagnesemia), which in turn worsens hypokalemia. Prevention: vigorous saline hydration (chloride diuresis); amifostine, a free-radical scavenger, is an option. • Ototoxicity: reactive oxygen species damage outer hair cells in the basal turn of the cochlea, producing irreversible high-frequency sensorineural hearing loss and tinnitus. Sodium thiosulfate is approved to reduce ototoxicity in children with localized, nonmetastatic solid tumors. • Peripheral sensory neuropathy and severe nausea and vomiting (highly emetogenic).
High-yield summary: Cisplatin (like carboplatin and oxaliplatin) cross-links DNA; cisplatin causes nephrotoxicity with hypomagnesemia, ototoxicity, peripheral neuropathy, and severe emesis.
Why the other options are wrong
- A. Inhibition of topoisomerase II — Etoposide inhibits topoisomerase II, causing double-strand DNA breaks. Its main toxicities are myelosuppression, alopecia, mucositis, and secondary acute myeloid leukemia; it does not cause ototoxicity or renal magnesium wasting.
- B. Generation of free radicals that cause DNA strand breaks — Bleomycin binds iron and generates free radicals that cause DNA strand breaks. Its characteristic toxicities are pulmonary fibrosis (with decreased DLCO) and skin changes (hyperpigmentation, flagellate dermatitis); it causes minimal myelosuppression and no hearing loss. This patient's DLCO is normal.
- C. Inhibition of dihydrofolate reductase — Methotrexate inhibits dihydrofolate reductase. It causes myelosuppression and mucositis (rescued by leucovorin), hepatotoxicity, and pneumonitis, and high doses can cause crystal nephropathy, but it is not ototoxic and is not part of standard germ cell tumor regimens.
- E. Inhibition of microtubule polymerization — Vinca alkaloids (vinblastine, vincristine) bind β-tubulin and inhibit microtubule polymerization, arresting cells in M phase. Vinblastine causes myelosuppression, and vincristine causes peripheral neuropathy and constipation; neither causes ototoxicity or renal Mg2+ wasting.
Key point
Cisplatin forms DNA cross-links (mainly intrastrand) and characteristically causes ototoxicity (high-frequency sensorineural hearing loss), nephrotoxicity with hypomagnesemia, and peripheral neuropathy.
Memory hook
Platinum handcuffs adjacent guanines together (intrastrand cross-links). Heavy metal, heavy toll: ears (high-tone hearing loss), kidneys (↓Mg²⁺), nerves, relentless vomiting.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free